DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response /MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e161-e162
Main Authors: Gozzetti, Alessandro, Raspadori, Donatella, Bacchiarri, Francesca, Pacelli, Paola, Di Martino, Francesca, Liberati, Anna Marina, Sicuranza, Anna, Lombardo, Alessandra, Caffarelli, Cristiana, Antonioli, Elisabetta, Staderini, Michela, Tocci, Dania, Crupi, Rosaria, Bosi, Alberto, Bocchia, Monica
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.269